A unique blend of forum and network, the Cardiovascular (CV) Team Member Section and Leadership Council is advancing ACC's efforts to identify and address gaps in areas of professional importance to ...

On behalf of the ACPC leadership council, I extend a warm welcome to all our existing and new section members. I am pleased to update you on the exciting initiatives within our section that enhance ...

I am so honored to serve as the ACC WIC Leadership Council and Section Chair for 2022 to 2025. I am dedicated to enhancing our profession by engaging, preparing, and promoting women in leadership, ...

CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(MODEST), Edwards Lifesciences(MODEST) SPEAKER'S BUREAU: Abbott Vascular(MODEST), Edwards Lifesciences(MODEST), MSD(MODEST ...

The Heart Valve Collaboratory has proposed a framework to standardize best practices for using multimodality imaging in transcatheter valve failure (TVF) following transcatheter aortic valve ...

According to a new study published in JACC, there is a strong dose-response relationship between cigarette smoking and three different domains of subclinical cardiovascular markers: inflammation, ...

Join Us When you become a member of the American College of Cardiology, you join a global community of cardiovascular professionals driven to transform cardiovascular care and improve heart health.

Studies in all JACC journals are embargoed until they are published online. The chart below details the general embargo time and day for each journal; however, these dates are subject to change and ...

Women with a history of gestational diabetes (GD) who sleep less than seven hours per day and snore frequently have a significantly increased risk of developing type 2 diabetes (T2D), according to a ...

Although the 2024 ACC/American Heart Association (AHA) and 2023 European Society of Cardiology (ESC) guidelines stratify well overall the risk of sudden cardiac death (SCD) in patients with ...

A State-of-the-Art Review published March 10 in JACC: Cardiovascular Interventions highlights a proposed treatment algorithm for the endovascular revascularization of femoropopliteal lesions and ...

Treatment of severe heart failure (HF) across the spectrum of LVEF with the SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of cardiovascular death or worsening HF ...